Medical Director, Oncology Clinical Development
GSK
15 days ago
Remote friendly (Collegeville, PA)
United States
Clinical Research and Development
Medical Director, Oncology Clinical Development
On-site presence: Minimum two days/week in one of GSK’s UK (London or Stevenage), US (Greater Philadelphia or Waltham), Canada (Mississauga), Switzerland (Zug) or Poland (Warsaw) campuses.
Key Responsibilities
- Collaborate in a matrix environment to develop and execute phase 1–3 interventional clinical trials.
- Provide medical expertise for end-to-end clinical trial delivery (protocol concept to final study report), ensuring patient safety, scientific integrity, and alignment with clinical development strategy.
- Ensure high-quality protocol development aligned with the early Clinical Development Plan.
- Assume medical responsibility for early phase trials, including real-time medical monitoring, patient eligibility, study design questions, and urgent safety questions (incl. Safety/PV as relevant).
- Review clinical trial data (directly and/or via oversight).
- Review/monitor safety data with pharmacovigilance.
- Interpret/summarize results (safety, efficacy, PK/PD, patient-reported outcomes) and applicability to the target population.
- Author clinical study reports and regulatory documents; respond to health authority and ethics committee queries.
- Co-author publications based on clinical data.
- Network for strategic partnerships; serve as core member of Early Development Team.
- Participate in Oncology Clinical Development initiatives/workstreams.
Basic Qualifications
- Medical degree with board certification/eligibility or registration in medical oncology, hematology, or hematology/oncology.
- Experience in pharma/biotech, clinical academic medicine, or clinical practice in hematology and/or oncology.
- Oncology clinical drug development experience conducting clinical trials and subsequent publications.
Preferred Qualifications
- MD/PhD preferred.
- Experience managing hematological malignancy patients; research/drug development focused on hematological malignancies (e.g., multiple myeloma).
- Knowledge of biological mechanisms, clinical strategy, translational research, competitor landscape, and treatment guideline evolution.
Compensation/Benefits (if based in US/explicitly stated)
- Annual base salary range (Cambridge, MA/Waltham, MA/Rockville, MD/San Francisco, CA): $222,750–$371,250; annual bonus and eligibility for share-based long-term incentive.
- Benefits include health care/insurance, retirement, paid holidays/vacation, and paid caregiver/parental and medical leave.
On-site presence: Minimum two days/week in one of GSK’s UK (London or Stevenage), US (Greater Philadelphia or Waltham), Canada (Mississauga), Switzerland (Zug) or Poland (Warsaw) campuses.
Key Responsibilities
- Collaborate in a matrix environment to develop and execute phase 1–3 interventional clinical trials.
- Provide medical expertise for end-to-end clinical trial delivery (protocol concept to final study report), ensuring patient safety, scientific integrity, and alignment with clinical development strategy.
- Ensure high-quality protocol development aligned with the early Clinical Development Plan.
- Assume medical responsibility for early phase trials, including real-time medical monitoring, patient eligibility, study design questions, and urgent safety questions (incl. Safety/PV as relevant).
- Review clinical trial data (directly and/or via oversight).
- Review/monitor safety data with pharmacovigilance.
- Interpret/summarize results (safety, efficacy, PK/PD, patient-reported outcomes) and applicability to the target population.
- Author clinical study reports and regulatory documents; respond to health authority and ethics committee queries.
- Co-author publications based on clinical data.
- Network for strategic partnerships; serve as core member of Early Development Team.
- Participate in Oncology Clinical Development initiatives/workstreams.
Basic Qualifications
- Medical degree with board certification/eligibility or registration in medical oncology, hematology, or hematology/oncology.
- Experience in pharma/biotech, clinical academic medicine, or clinical practice in hematology and/or oncology.
- Oncology clinical drug development experience conducting clinical trials and subsequent publications.
Preferred Qualifications
- MD/PhD preferred.
- Experience managing hematological malignancy patients; research/drug development focused on hematological malignancies (e.g., multiple myeloma).
- Knowledge of biological mechanisms, clinical strategy, translational research, competitor landscape, and treatment guideline evolution.
Compensation/Benefits (if based in US/explicitly stated)
- Annual base salary range (Cambridge, MA/Waltham, MA/Rockville, MD/San Francisco, CA): $222,750–$371,250; annual bonus and eligibility for share-based long-term incentive.
- Benefits include health care/insurance, retirement, paid holidays/vacation, and paid caregiver/parental and medical leave.